Risk factors for multidrug-resistant bacteria in patients with post-operative peritonitis requiring intensive care | Zendy

Philippe Séguin | Zendy; Yannick Fédun | Zendy; Bruno Laviolle | Zendy; Nicolas Nesseler | Zendy; Pierre-Yves Donnio | Zendy; Yannick Mallédant | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Risk factors for multidrug-resistant bacteria in patients with post-operative peritonitis requiring intensive care

Author(s) -

Philippe Séguin,

Yannick Fédun,

Bruno Laviolle,

Nicolas Nesseler,

Pierre-Yves Donnio,

Yannick Mallédant

Publication year - 2009

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkp439

Subject(s) - medicine , imipenem , piperacillin , ticarcillin , tazobactam , cefotaxime , intensive care unit , clavulanic acid , amikacin , meropenem , amoxicillin , intensive care medicine , antibiotics , antibiotic resistance , microbiology and biotechnology , pseudomonas aeruginosa , genetics , bacteria , biology

This prospective non-interventional study investigated the risk factors for multidrug-resistant bacteria (MDRB) in patients with post-operative peritonitis (POP), to provide guidance for empirical antimicrobial therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research